Nasdaq:US$17.69 (-2.18) | HKEX:HK$29.50 (-2.25) | AIM:£2.98 (-0.36)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 6 Jun 2012

Hutchison MediPharma Limited Announces Presentations of Sulfatinib and Fruquintinib Clinical Data at the 2012 ASCO Annual Meeting